Delayed-release pharmaceutical formulations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 18, 2004
app pub date -
Oct 15, 2003
filing date -
Nov 10, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to a pharmaceutical delayed-release formulation containing proinsulin C-peptide and the use of the delayed-release formulations for treating of diabetes. In particular, the invention relates to delayed-release formulations in which proinsulin C-peptide is present in an absorbable matrix consisting for example of absorbable polymers. The invention also relates to microparticles which contain proinsulin C-peptide.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully